Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
baseline level | concentration measured before a defined change | The baseline level predates the formulation switch. | Objective | Drug levels - collection and dose timing |
calendar date | date attached to an event or measurement | Record the calendar date for each dose when interpreting overnight samples. | Plan | Monitoring actions, escalation and result communication |
| resolve a specific uncertainty | Clarify the timing of the rash relative to the first dose. | Plan | Investigation and monitoring | |
collection time | when the specimen was actually obtained | The collection time was 07:42 according to the laboratory record. | Objective | Drug levels - collection and dose timing |
collection window | drug- and protocol-specific period intended for sampling | The draw occurred within the specified collection window. | Objective | Drug levels - collection and dose timing |
cyclosporine | immunosuppressant monitored using a specified timed sampling strategy | The cyclosporine report specifies whether the order was for a predose or two-hour sample. | Objective | Drug levels - named analytes and exposure reports |
dexamethasone suppression test | assessment of cortisol suppression after a specified dexamethasone regimen | The dexamethasone suppression test was documented with dose timing and collection time. | Objective | Glucose monitoring, endocrine testing and urine studies |
dilute | reduce concentration by adding a compatible diluent | Verify the product-specific instructions before staff dilute the dose. | Plan | Medication planning, access and administration |
discard-date labeling | marking the date a product should be discarded under its product-specific instructions | Review discard-date labeling for the opened multidose device. | Plan | Medication reconciliation, administration and teaching |
discontinuation symptoms | symptoms emerging after reducing or stopping a medication | Discontinuation symptoms began shortly after the last regular dose. | Assessment | Medication response, exposure and reconciliation |
| difference between sources that requires explanation | The home bottle and discharge list show a dose discrepancy. | Assessment | Risk, goals, medication assessment and function | |
discriminating feature | detail that helps distinguish competing explanations | Discriminating feature was the reproducible relation to the actual dose time. | Assessment | Precision in clinical interpretation and documentation |
dosing history | times and amounts actually received | The available dosing history covers the three administrations preceding the specimen. | Objective | Drug levels - collection and dose timing |
doubled | twice the usual quantity was taken | Reports having doubled one dose after misreading the label. | Subjective | Sequence, exposures and use of medicines |
double vision | seeing two images of one object | The patient reports intermittent double vision after the dose change. | Subjective | Medication history, adherence and level-related symptoms |
draw site | location or access used for collection | The documented draw site was a peripheral vein in the opposite arm. | Objective | Drug levels - collection and dose timing |
| time between two identified events | The elapsed time from infusion completion to collection was 40 minutes. | Objective | Drug levels - collection and dose timing | |
empty stomach | taken without food by the patient's account | The patient recalls taking the last dose on an empty stomach. | Subjective | Medication history, adherence and level-related symptoms |
end of infusion | time when drug delivery actually finished | The end of infusion was recorded at 10:12 in the pump history. | Objective | Drug levels - collection and dose timing |
extended-release | formulation designed to release drug over a longer interval | The verified product is extended-release, which affects interpretation of dose timing. | Assessment | Medication exposure, response and adverse-effect reasoning |
factor IX activity | functional activity of factor nine in a coagulation assay | Factor IX activity was measured before the documented replacement dose. | Objective | Coagulation, antibodies and hemostasis studies |
flucytosine | antifungal monitored using drug- and protocol-specific sampling | The flucytosine sample is documented with its exact postdose interval. | Objective | Drug levels - named analytes and exposure reports |
home laboratory draw | blood collection performed at the patient's residence | Coordinate the home laboratory draw with the morning dose schedule. | Plan | Therapies, devices and interdisciplinary care |
immediate-release | formulation that releases drug without a designed delay or extension | The earlier level followed an immediate-release dose. | Assessment | Medication exposure, response and adverse-effect reasoning |
infuse | administer a fluid or drug over a defined duration | The signed order specifies how long to infuse the dose. | Plan | Medication planning, access and administration |